Morgan Stanley Minerva Surgical Inc Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.2 - $0.5 $3,357 - $8,394	-16,788 Reduced 64.5%	9,240 $2,000
Q4 2022 Feb 14, 2023	BUY	$0.16 - $16.8 $4,164 - $437,270	26,028 New	26,028 $5,000
Q2 2022 Aug 15, 2022	SELL	$1.75 - $4.5 $17,500 - $45,000	-10,000 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$4.26 - $5.82 $42,600 - $58,200	10,000 New	10,000 $45,000
Q1 2022 May 13, 2022	BUY	$4.26 - $5.82 $42,582 - $58,176	9,996 Added 249900.0%	10,000 $45,000
Q4 2021 Feb 14, 2022	BUY	$4.53 - $9.78 $18 - $39	4 New	4 $0

Ticker UTRS
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 28,860,000
Market Cap $289K
Description
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation de...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.